Trials / Unknown
UnknownNCT03330626
VolumE maNagement Under Body Composition Monitoring in Critically Ill patientS on CRRT
VolumE maNagement Under Body Composition Monitoring in Critically Ill patientS on CRRT; Randomized-controlled Trial (VENUS Trial)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 244 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Although monitoring fluid balance for continuous renal replacement therapy-treated patients is an important issue, most physicians usually use conventional methods such as the difference between the amount of intake and output (I \& O), which is not objective way. Meanwhile, bioimpedance electrical vector analysis presents the patients' fluid status with more objective data. Thus, the investigators will investigate the clinical benefit for monitoring fluid balance when the investigators use InBody S10, one of representative bioimpedance electrical vector analysis, compared with conventional methods among the patients who need continuous renal replacement therapy.
Detailed description
Although monitoring fluid balance for continuous renal replacement therapy-treated patients is an important issue, most physicians usually use conventional methods such as the difference between the amount of intake and output (I \& O), which is not objective way. Meanwhile, bioimpedance electrical vector analysis presents the patients' fluid status with more objective data. Thus, the investigators will investigate the clinical benefit for monitoring fluid balance by using InBody S10 (0, 1, 2-day, and 7-day from CRRT initiation), one of representative bioimpedance electrical vector analysis, compared with conventional methods among the patients who need continuous renal replacement therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | InBody group | As one of representative BIVA, it provides the patients' fluid status with more objective data such as TBW, ECW, ICW, etc. |
| OTHER | IO group | Fluid removal are guided by intake-output balance. |
Timeline
- Start date
- 2017-07-01
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2017-11-06
- Last updated
- 2017-11-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03330626. Inclusion in this directory is not an endorsement.